ClearNote Health will be at TRI-CON 2025. Meet us at booth 3 and learn more about ClearNote Health’s Virtuoso Epigenomics Platform. Virtuoso leverages 5hmC epigenomic profiling to uncover active cancer biology patterns from cfDNA in plasma, empowering more efficient oncology drug discovery and development.
Don’t miss the talk from our Chief Scientific Officer, Samuel Levy, PhD.
Talk: Epigenomic Liquid Biopsy Tools for Individualized Signals of Therapy Response
When: Tuesday, March 11, 2025, 2:25 – 2:55 PM
Track: Liquid Biopsy